TY  - GEN
AU  - Chang,Anne Lynn S
AU  - Tran,Duy C
AU  - Cannon,John G D
AU  - Li,Shufeng
AU  - Jeng,Mark
AU  - Patel,Roma
AU  - Van der Bokke,Lindsay
AU  - Pague,Alana
AU  - Brotherton,Richard
AU  - Rieger,Kerri E
AU  - Satpathy,Ansuman T
AU  - Yost,Kathryn E
AU  - Reddy,Sunil
AU  - Sarin,Kavita
AU  - Colevas,A Dimitrios
TI  - Pembrolizumab for advanced basal cell carcinoma: An investigator-initiated, proof-of-concept study
SN  - 1097-6787
PY  - 2019///0306
KW  - Anilides
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Agents, Immunological
KW  - Carcinoma, Basal Cell
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Dose-Response Relationship, Drug
KW  - Drug Administration Schedule
KW  - Female
KW  - Humans
KW  - Infusions, Intravenous
KW  - Male
KW  - Neoplasm Invasiveness
KW  - pathology
KW  - Neoplasm Staging
KW  - Prognosis
KW  - Prospective Studies
KW  - Pyridines
KW  - Risk Assessment
KW  - Skin Neoplasms
KW  - Survival Analysis
KW  - Treatment Outcome
N1  - Publication Type: Comparative Study; Controlled Clinical Trial; Journal Article
UR  - https://doi.org/10.1016/j.jaad.2018.08.017
ER  -